Michael Morgan

Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

Richard F. Schlenk, Konstanze Döhner, Jürgen Krauter et al. · New England Journal of Medicine · 2008 · 1.6K citations

Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes

Felicitas Thol, Sofia Kade, Carola Schlarmann et al. · Blood · 2012 · 417 citations · Full text

Incidence and Prognostic Influence of <i>DNMT3A</i> Mutations in Acute Myeloid Leukemia

Felicitas Thol, Frédérik Damm, Andrea Lüdeking et al. · Journal of Clinical Oncology · 2011 · 375 citations · Full text

Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors

Sihong Song, Michael Morgan, Tamir Ellis et al. · Proceedings of the National Academy of Sciences · 1998 · 305 citations · Full text

Viral Replication, Human Growth, Viral Pathogenesis +18

Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

Christoph Reuter, Michael Morgan, Lothar Bergmann · Blood · 2000 · 296 citations